Integer's stock plummeted 5.02% intraday on Friday, following a negative analyst note from Citi.

Citi lowered its price target on Integer to $89 from $92 while maintaining a Neutral rating on the shares. This reduction in price target may have contributed to investor concerns and selling pressure.

Analysts have recently been offering insights on healthcare companies including Integer Holdings, but the specific downgrade from Citi appears to have driven the sharp decline.